Diagnosis and Management of Hepatosplenomegaly with Lymphedema

Diagnostic Approach

The combination of hepatosplenomegaly and lymphedema strongly suggests an underlying storage disorder, particularly Acid Sphingomyelinase Deficiency (ASMD) or another lysosomal storage disease, which requires prompt genetic testing and multidisciplinary management, as recommended by the American College of Medical Genetics and Genomics 1, 2
Lipid profile to identify mixed dyslipidemia with decreased HDL, characteristic of storage disorders like ASMD, is suggested by the National Lipid Association 1, 2
Liver function tests to assess hepatic involvement are recommended by the American Association for the Study of Liver Diseases 1
Chest X-ray or CT to evaluate for interstitial lung disease, which commonly accompanies ASMD, is advised by the American Thoracic Society 1, 3

Acid Sphingomyelinase Deficiency (ASMD) - characterized by hepatosplenomegaly, lymphedema, mixed dyslipidemia with low HDL, and interstitial lung disease, as described by the European Society of Human Genetics 1, 3
Cardio-facio-cutaneous syndrome (CFC) - may present with lymphedema and hepatosplenomegaly, according to the American Academy of Pediatrics 5, 6
Autoinflammatory diseases - such as cryopyrin-associated periodic syndromes (CAPS) can present with hepatosplenomegaly, as noted by the European League Against Rheumatism 7

Refer to a metabolic disease specialist for confirmation of diagnosis and management of suspected ASMD, as recommended by the Society for Inherited Metabolic Disorders 1, 3
Monitor liver function, lipid profile, and pulmonary function regularly in patients with ASMD, as advised by the American College of Medical Genetics and Genomics 1, 3
Evaluate for signs of portal hypertension and liver fibrosis in patients with ASMD, as suggested by the American Association for the Study of Liver Diseases 1, 2

Genetic testing for SMPD1 gene mutations if ASMD is suspected, as recommended by the European Society of Human Genetics 3, 2
Multigene Ras/MAPK pathway panel testing if CFC syndrome is suspected, as advised by the American Academy of Pediatrics 5, 6
Pulmonary function testing to assess for restrictive pattern with low diffusing capacity in patients with ASMD, as suggested by the American Thoracic Society 1, 3